Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Corazon (Corsee) D. Sanders files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Howard Horn - $1.33M of RARE open-market activity in the last 12 months
- Emil D. Kakkis - $1.24M of RARE open-market activity in the last 12 months
- Karah Herdman Parschauer - $564K of RARE open-market activity in the last 12 months
- Erik Harris - $240K of RARE open-market activity in the last 12 months
- John Richard Pinion - $229K of RARE open-market activity in the last 12 months
- Eric Crombez - $169K of RARE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Corazon (Corsee) D. Sanders?
Corazon (Corsee) D. Sanders is a corporate insider, tracked as Director of Calidi Biotherapeutics, Inc. (CLDI). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Corazon (Corsee) D. Sanders submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Corazon (Corsee) D. Sanders been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.91M) across all tracked filings.
Where can I see all of Corazon (Corsee) D. Sanders's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Corazon (Corsee) D. Sanders and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
